Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

[Bone marrow stromal cells transfected with ciliary neurotrophic factor gene ameliorates the symptoms and inflammation in C57BL/6 mice with experimental allergic encephalomyelitis].

Lu ZQ, Hu XQ, Zhu CS, Zheng XP, Wan DJ, Liu RY, Huang BJ, Huang WL.

Nan Fang Yi Ke Da Xue Xue Bao. 2009 Dec;29(12):2355-61. Chinese.

2.

Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.

Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q.

J Neuroimmunol. 2009 Jan 3;206(1-2):58-69. doi: 10.1016/j.jneuroim.2008.10.014. Epub 2008 Dec 9.

PMID:
19081144
3.

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G, Uccelli A.

Blood. 2005 Sep 1;106(5):1755-61. Epub 2005 May 19.

4.

Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.

Kuhlmann T, Remington L, Cognet I, Bourbonniere L, Zehntner S, Guilhot F, Herman A, Guay-Giroux A, Antel JP, Owens T, Gauchat JF.

Am J Pathol. 2006 Aug;169(2):584-98.

5.

Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.

Hou Y, Ryu CH, Park KY, Kim SM, Jeong CH, Jeun SS.

Stem Cell Res Ther. 2013 Jul 5;4(4):77. doi: 10.1186/scrt228.

6.

CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.

Linker RA, Mäurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R.

Nat Med. 2002 Jun;8(6):620-4.

PMID:
12042814
7.
8.

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.

Murphy AC, Lalor SJ, Lynch MA, Mills KH.

Brain Behav Immun. 2010 May;24(4):641-51. doi: 10.1016/j.bbi.2010.01.014. Epub 2010 Feb 6.

PMID:
20138983
9.

HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.

Furlan R, Bergami A, Brambilla E, Butti E, De Simoni MG, Campagnoli M, Marconi P, Comi G, Martino G.

Gene Ther. 2007 Jan;14(1):93-8. Epub 2006 Aug 24.

PMID:
16929354
11.

Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D.

Arch Neurol. 2008 Jun;65(6):753-61. doi: 10.1001/archneur.65.6.753.

PMID:
18541795
12.

Transfer of severe experimental autoimmune encephalomyelitis by IL-12- and IL-18-potentiated T cells is estrogen sensitive.

Ito A, Matejuk A, Hopke C, Drought H, Dwyer J, Zamora A, Subramanian S, Vandenbark AA, Offner H.

J Immunol. 2003 May 1;170(9):4802-9.

13.
14.

Periplocoside E inhibits experimental allergic encephalomyelitis by suppressing interleukin 12-dependent CCR5 expression and interferon-gamma-dependent CXCR3 expression in T lymphocytes.

Zhu YN, Zhong XG, Feng JQ, Yang YF, Fu YF, Ni J, Liu QF, Tang W, Zhao WM, Zuo JP.

J Pharmacol Exp Ther. 2006 Sep;318(3):1153-62. Epub 2006 Jun 2.

15.

Interferon-gamma confers resistance to experimental allergic encephalomyelitis.

Krakowski M, Owens T.

Eur J Immunol. 1996 Jul;26(7):1641-6.

PMID:
8766573
16.

Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.

Nishihara K, Barth RF, Wilkie N, Lang JC, Oda Y, Kikuchi H, Everson MP, Lotze MT.

Cancer Gene Ther. 1995 Jun;2(2):113-24.

PMID:
7621259
17.

Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.

Payne NL, Sun G, McDonald C, Layton D, Moussa L, Emerson-Webber A, Veron N, Siatskas C, Herszfeld D, Price J, Bernard CC.

Cell Transplant. 2013;22(8):1409-25. doi: 10.3727/096368912X657620. Epub 2012 Oct 4.

PMID:
23057962
18.

Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.

Hong X, Miller C, Savant-Bhonsale S, Kalkanis SN.

Neurosurgery. 2009 Jun;64(6):1139-46; discussion 1146-7. doi: 10.1227/01.NEU.0000345646.85472.EA.

PMID:
19487894
20.

Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.

Cuerquis J, Romieu-Mourez R, François M, Routy JP, Young YK, Zhao J, Eliopoulos N.

Cytotherapy. 2014 Feb;16(2):191-202. doi: 10.1016/j.jcyt.2013.11.008.

PMID:
24438900

Supplemental Content

Support Center